ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1620115
A prospective non-randomized interventional study of dynamic changes of L3SMI in patients with gastric cancer undergoing ambulatory chemotherapy with active nutrition combined with exercise
Provisionally accepted- 1Ordos Central Hospital, Dongsheng, China
- 2Wenzhou Medical University, Wenzhou, Zhejiang Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To compare the effects of combined active nutrition and exercise intervention based on a standard regimen on the dynamic changes in the L3 skeletal muscle index (L3SMI) of patients with gastric cancer receiving SOX/XELOX ambulatory chemotherapy, and explore its relationship with chemotherapy-related adverse reactions. Methods: This prospective non-randomized interventional study was conducted on patients with gastric cancer who received adjuvant or first-line SOX/XELOX ambulatory chemotherapy at Ordos Central Hospital, China, from June 2021 to December 2024. Patients receiving active nutrition and exercise intervention were defined as the intervention group, and those receiving conventional standard treatment were the control group.Compare the differences in each indicator between the two groups at the two time points before and after the intervention. Nutritional intake was assessed using the Brief Conghua scale. Nutritional management was based on the five-step nutrition program recommended in the Chinese Cancer Nutrition Treatment Guidelines 2020. The exercise program was based on FITT(frequency, intensity, time, and type) mode. WeChat was used to provide patients with education and technical guidance. Neutropenia was graded according to the Common Terminology Criteria for Adverse Events version 5.0. Results: Dynamic follow-up was completed in 77 patients, including 39 in the intervention group and 38 in the control group. The intervention group showed a positive change in the L3SMI compared to that in the control group (P = 0.0032). The case-control 删除[作者]: comparison 删除[作者]:SMI remained stable or increased in 64.1% (25/39) of patients in the intervention group and 31.6% (12/38) in the control group. The incidence of grade ≥3 neutropenia in the intervention group was lower than that in the control group (P = 0.0011).Active nutrition and exercise intervention can improve L3SMI and reduce the incidence of grade ≥3 neutropenia in patients with gastric cancer receiving SOX/XELOX ambulatory chemotherapy.
Keywords: Clinical Registration Number Registration website link::www.chictr.org.cn Registration number: ChiCTR2200056758 and ChiCTR2300071748 L3 skeletal muscle index, nutrition intervention, Exercise Intervention, Ambulatory chemotherapy, Sarcopenia
Received: 29 Apr 2025; Accepted: 22 Jul 2025.
Copyright: © 2025 Zhao, Zhenhao, Li and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shurong Zhao, Ordos Central Hospital, Dongsheng, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.